Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 180

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

835	NVLX Pancreatic Cancer Cures?	stocklegend	04/04/2014 1:55:45 PM
834	NVLX Dr.Von Hoff is the one who developed	stocklegend	04/04/2014 1:06:50 PM
833	NVLX Hot News:	stocklegend	04/04/2014 11:56:20 AM
832	NVLX The Nuvilex team presents us with a new tool	stocklegend	04/04/2014 11:04:02 AM
831	NVLX That loud noise you hear coming from	stocklegend	04/04/2014 10:17:36 AM
830	NVLX Nuvilex Investors Should Read Between the	stocklegend	04/04/2014 9:13:44 AM
829	NVLX Translational Drug Development or TD2 will	stocklegend	04/03/2014 2:04:45 PM
828	NVLX Dr. Daniel Von Hoff, the world's leading	stocklegend	04/03/2014 1:10:23 PM
827	NVLX That loud noise you hear coming from	stocklegend	04/03/2014 11:15:31 AM
826	NVLX Nuvilex Investors Should Read Between the	stocklegend	04/03/2014 10:05:15 AM
825	NVLX Pancreatic Cancer Cures?	stocklegend	04/03/2014 9:16:18 AM
824	NVLX Dr.Von Hoff is the one who developed	stocklegend	04/02/2014 1:57:20 PM
823	NVLX Hot News:	stocklegend	04/02/2014 12:32:50 PM
822	NVLX The Nuvilex team presents us with a new tool	stocklegend	04/02/2014 11:53:13 AM
821	NVLX About Nuvilex: Nuvilex is a clinical-stage	stocklegend	04/02/2014 10:51:16 AM
820	NVLX A clinical-stage international	stocklegend	04/02/2014 10:00:40 AM
819	NVLX Pancreatic Cancer Cures?	stocklegend	04/02/2014 9:03:46 AM
818	Dr. Von Hoff is THE LEADING FIGURE in pancreatic	Tandrel	04/02/2014 9:03:17 AM
817	NVLX "We are honored that TD2 and Dr. Von Hoff	stocklegend	04/01/2014 2:25:58 PM
816	NVLX The PCRT, an affiliate of TD2, has the	stocklegend	04/01/2014 1:20:46 PM
815	NVLX Dr. Von Hoff is the one who developed	stocklegend	04/01/2014 12:14:36 PM
814	NVLX "Our Pancreatic Cancer Research Team (PCRT)	stocklegend	04/01/2014 11:29:49 AM
813	NVLX "The Nuvilex team presents us with a new	stocklegend	04/01/2014 10:15:37 AM
812	NVLX NEWS:	stocklegend	04/01/2014 9:35:17 AM
811	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	04/01/2014 9:08:03 AM
810	$NVLX With live-cell encapsulation, depending on	Tandrel	04/01/2014 8:27:23 AM
809	$NVLX ~ Here's a simple Nuvilex chart:	Tandrel	04/01/2014 8:25:12 AM
808	$NVLX's live-cell encapsulation technology is a	Tandrel	04/01/2014 8:23:22 AM
807	$NVLX Investors Confidently Back Nuvilex's	stocklegend	03/31/2014 1:57:24 PM
806	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	03/31/2014 1:47:30 PM
805	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	03/31/2014 12:48:10 PM
804	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	03/31/2014 11:07:25 AM
803	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	03/31/2014 10:21:04 AM
802	$NVLX Nuvilex Begins Making Moves at its	stocklegend	03/31/2014 9:47:58 AM
801	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	03/31/2014 9:04:02 AM
800	$NVLX has acquired worldwide exclusive rights to	Tandrel	03/31/2014 8:45:09 AM
799	$NVLX Company info and share structure	Tandrel	03/31/2014 8:42:59 AM
798	$NVLX ~ Here's a simple Nuvilex chart:	Tandrel	03/31/2014 8:39:41 AM
797	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	03/28/2014 3:36:50 PM
796	$NVLX Nuvilex Begins Making Moves at its	stocklegend	03/28/2014 3:35:42 PM
795	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	03/28/2014 1:29:57 PM
794	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	03/28/2014 12:15:00 PM
793	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	03/28/2014 11:33:26 AM
792	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	03/28/2014 11:13:50 AM
791	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	03/28/2014 10:24:08 AM
790	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	03/28/2014 9:56:10 AM
789	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	03/28/2014 9:23:52 AM
788	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	03/27/2014 2:49:03 PM
787	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	03/27/2014 1:21:34 PM
786	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	03/27/2014 12:51:40 PM

Newer

Older

Recent Articles

• Elon Musk's Tweet on a Sink: Unpacking Its Mysterious Meaning
• North Korea's Oil and Military Dealings with Russia Explored
• Trump's Ambitious DOJ Revamp: What It Means for America
• Russell Vought Appointed as OMB Director by Trump
• RWA Inc Launches $RWA Token, Transforming Asset Tokenization
• Elon Musk Advocates for Release of Jeffrey Epstein Files
• Trudeau Denounces Violence Amid NATO Assembly in Montreal
• Chavez-DeRemer's Selection as Labor Secretary: What It Means
• Tesla Cybertruck: A New Role in Presidential Security?
• Representative Laurel Lee's Strategic Stock Moves in 2024
• Marjorie Taylor Greene Expands Investment Portfolio with Stocks
• Suzan K. DelBene's Strategic Investments in Government Securities
• Recent Sale of State Street Corporation Stock by Auchincloss
• Elon Musk's Post Ignites Dogecoin Growth Amid X Payments Buzz
• Global Cooperation on Carbon Credit Trading Sets Standards
• Iris Energy Limited Investors Must Act by December 6, 2024
• DEA's Random Search Ban: A Deep Dive into Corruption Findings
• Investors Take Action: Edwards Lifesciences Faces Lawsuit
• Brooke Rollins: A Potential New Face in U.S. Agriculture Leadership
• Goldman Sachs Faces Major Write-Off after Northvolt Bankruptcy
• Musk's Court Victory Against SEC Marks Key Legal Turning Point
• New U Life Triumphs in Legal Battle: Awakend's Appeal Failed
• Adani Energy Solutions Addresses Kenya Project Cancellation Impact
• Whale Activity in Dogecoin Surges with $214.5 Million Purchase
• Investors Urged to Act: Paragon 28 Lawsuit Insights
• Thanksgiving Costs and Travel Trends Amid Inflation Insights
• Market Movers: Insights on Coinbase, MicroStrategy, and More
• Bosch's Strategic Shift: Reducing Hours for Thousands in Germany
• Investigation of Mergers: MKFG, CYTH, BRKH, and CFB Explored
• Wolfspeed Investors: Join the Fight for Justice and Recovery
• Legal Action for ASML Investors: Take Charge Now
• Short Selling: A Growing Trend Amid Market Fluctuations
• Lead Class Action Opportunity for Hasbro Investors Amid Losses
• Xerox Holdings Corporation Class Action: Key Investor Info
• Election Outcomes Signal Shift in Housing Support and Strategies
• Mark Cuban Advocates for Leadership Growth Over Micromanagement
• Spirit Airlines Takes Strategic Step With Chapter 11 Filing
• Investors Urged to Join Class Action Against PACS Group Inc.
• Nvidia's Future Looks Bright as Chip Demand Remains Strong
• Robert Kiyosaki Champions Bitcoin Investment Strategy by Saylor
• Investors Encouraged to Seek Legal Counsel for $JENNER Case
• UPS and BIT Mining Fined in Major Financial Misconduct Cases
• Allan Leighton Returns to Lead Asda as Executive Chairman
• Kaskela Law Investigates Innovid Corp. Buyout Deal for Investors
• Concerns Arise Over Zuora, Inc. Shareholder Privileges Amid Acquisition
• MicroStrategy's Michael Saylor Hails $500M Daily Profit from Bitcoin
• Empowering Lilium N.V. Investors: Your Rights and Options
• Huawei Sets Ambitious Goal of 100,000 Apps on Harmony OS
• Brazil's Government Takes Action to Freeze Spending Amid Fiscal Rulings
• Understanding the Fed's Rate Strategy and Future Prospects